|
FAM105B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.89050000004776E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.697880E-03 |
| Normal-vs-Stage2 |
1.765590E-02 |
| Normal-vs-Stage3 |
9.483200E-03 |
| Normal-vs-Stage4 |
3.882800E-01 |
| Stage1-vs-Stage2 |
2.495600E-01 |
| Stage1-vs-Stage3 |
1.763190E-01 |
| Stage1-vs-Stage4 |
8.537200E-01 |
| Stage2-vs-Stage3 |
9.662600E-01 |
| Stage2-vs-Stage4 |
4.333400E-01 |
| Stage3-vs-Stage4 |
4.236000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.81090000000084E-05 |
| Normal-vs-AfricanAmerican |
3.958700E-03 |
| Normal-vs-Asian |
4.639800E-01 |
| Caucasian-vs-AfricanAmerican |
9.993800E-01 |
| Caucasian-vs-Asian |
7.538600E-01 |
| AfricanAmerican-vs-Asian |
7.691400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72971999999882E-05 |
| Normal-vs-Female |
2.275800E-03 |
| Male-vs-Female |
9.922000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.081400E-01 |
| Normal-vs-Extreme_Weight |
5.002300E-03 |
| Normal-vs-Obese |
8.03530000000885E-05 |
| Normal-vs-Extreme_Obese |
2.073800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.322590E-01 |
| Normal_Weight-vs-Obese |
1.000100E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.866800E-01 |
| Extreme_Weight-vs-Obese |
1.621000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.702400E-01 |
| Obese-vs-Extreme_Obese |
5.043000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.165000E-03 |
| Normal-vs-Age(41-60Yrs) |
7.83950000027289E-07 |
| Normal-vs-Age(61-80Yrs) |
4.438200E-03 |
| Normal-vs-Age(81-100Yrs) |
2.592400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.377200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.282600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.914600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.004000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.806800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.090800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.3340999999939E-05 |
| Normal-VS-Type2 PRCC |
2.579600E-03 |
| Normal-VS-KIRP CIMP |
8.726200E-01 |
| Normal-VS-Unclassified PRCC |
1.919270E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.748600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.223500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.156040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.824000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.655000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.181600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.718000E-02 |
| Normal-vs-N1 |
4.316600E-03 |
| Normal-vs-N2 |
8.422600E-01 |
| N0-vs-N1 |
1.907760E-01 |
| N0-vs-N2 |
6.852400E-01 |
| N1-vs-N2 |
3.493600E-01 |
|
|
